HOWARD MCLEOD, PHARM.D., IS MOFFITT'S FIRST CANCER RESEARCH ENDOWED CHAIR, as established by the Florida Legislature. Dr. McLeod serves as medical director of the DeBartolo Family Personalized Medicine Institute, which was founded to seek out and share targeted treatments with the aim of improving outcomes, curing disease, extending survivorship and improving quality of life for patients in Florida and beyond.
MOFFITT CANCER CENTER RECEIVED A $5 MILLION DONATION FROM CHRIS SULLIVAN, a restaurant developer and co-founder of Outback Steakhouse and its parent company Bloomin' Brands, Inc. The gift will help address the pressing need for more effective therapy for patients with melanoma. The contribution will support work at Moffitt's Donald A. Adam Comprehensive Melanoma Research Center of Excellence where researchers are sequencing the human genome and developing personalized treatments for melanoma to ultimately improve patient survival. Melanoma is the most common form of cancer for young adults 25 to 29 years old and the deadliest form of skin cancer.